pmn-elastase
Showing 1 - 25 of 114
Testing Fecal Biomarkers In Comparison To Endoscopic Examination
Recruiting
- Inflammatory Bowel Diseases
- Testing Fecal Biomarkers In Comparison To Endoscopic Examination With Confocal Laser Endomicroscopy
-
Bamberg, Bayern, GermanySozialstiftung Bamberg, Klinik für Intergrative Medizin
May 17, 2022
Crohn Disease Trial in Bamberg (lifestyle-modification, waiting control group)
Active, not recruiting
- Crohn Disease
- lifestyle-modification
- waiting control group
-
Bamberg, Bayern, GermanySozialstiftung Bamberg, Klinik für Intergrative Medizin
Feb 3, 2022
Periodontitis Trial in Istanbul (Initial periodontal treatment)
Completed
- Periodontitis
- Initial periodontal treatment
-
Istanbul, TurkeyBiruni University
Aug 12, 2022
Integrative Therapy of Chronic Diseases
Recruiting
- Chronic Disease
- multimodal integrative naturopathic therapy concept
-
Bamberg, Bayern, Germany
- +2 more
Jan 30, 2023
Kalydeco on Upper Airway and Paranasal Sinus Inflammation
Completed
- Inflammatory Changes in Epithelial Lining Fluid Sampled Non-invasively by Nasal Lavage in CF Patients With G551D Receiving Kalydeco
- nasal lavage (routine diagnostic procedure in our centre), assessment of symptoms
-
Jena, GermanyJena University Hospital, CF Center
Jul 8, 2021
Hyperspectral Imaging Technique in CTX Treatment of IMN
Not yet recruiting
- Hyperspectral Imaging
- +2 more
- Microscopic hyperspectral imaging system
- (no location specified)
Apr 29, 2023
Hyperspectral Imaging Technique in the Treatment of IMN by TAC
Not yet recruiting
- Idiopathic Membranous Nephropathy
- +2 more
- Tacrolimus for the treatment of IMN
- (no location specified)
Mar 31, 2023
Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)
Not yet recruiting
- Primary Membranous Nephropathy
- Obinutuzumab
- Oral prednisolone and cyclophosphamide
-
Garran, Australian Capital Territory, Australia
- +12 more
Nov 1, 2023
Membranous Nephropathy Trial in China (efgartigimod IV, )
Recruiting
- Membranous Nephropathy
- efgartigimod IV
- placebo
-
Changsha, China
- +8 more
Apr 11, 2023
Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
May 16, 2023
Pancreatic Exocrine Insufficiency Trial in Shanghai (Fecal pancreatic elastase 1 test)
Completed
- Pancreatic Exocrine Insufficiency
- Fecal pancreatic elastase 1 test
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 17, 2023
Acute Respiratory Distress Syndrome Trial (Sivelestat sodium)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Sivelestat sodium
- (no location specified)
Jan 3, 2023
Spontaneous Bacterial Peritonitis Trial in Sohag (ascitic fluid calprotectin)
Recruiting
- Spontaneous Bacterial Peritonitis
- ascitic fluid calprotectin
-
Sohag, EgyptSohag University Hospital
Aug 10, 2022
Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)
Recruiting
- Membranous Nephropathy - PLA2R Induced
- Rituximab, Cyclophosphamide, and Corticosteroids
-
Saint Petersburg, Russian FederationSt. Petersburg State Pavlov Medical University
Jan 7, 2023
Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)
Not yet recruiting
- Primary Membranous Nephropathy
- SNP-ACTH (1-39) Gel
- Rituximab
- (no location specified)
Jan 13, 2023
Covid19 Trial in Birmingham (Alvelestat, Placebo)
Airway Inflammation, Allergic Asthma Trial in Chapel Hill (Wood Smoke Particles (WSP))
Recruiting
- Airway Inflammation
- Allergic Asthma
- Wood Smoke Particles (WSP)
-
Chapel Hill, North CarolinaUNC Center For Environmental Medicine, Asthma and Lung Biology
Nov 15, 2022
Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor
Completed
- Asthma
- Bronchoscopy
-
Charlottesville, VirginiaUniversity of Virginia Health System
Feb 4, 2022
Exocrine Pancreatic Insufficiency
Recruiting
- Exocrine Pancreatic Insufficiency
- BÜHLMANN fPELA assay
-
Halle (Saale), GermanyUniversitätsklinikum Halle (Saale)
Mar 1, 2022
Pancreatic Cancer Using CA19-9 and Fecal Elastase
Active, not recruiting
- Paancreatic Cancer
-
Seoul, Korea, Republic ofGangnam Severance Hospital
Jun 27, 2023
Inflammatory Response, Cardiac Disease Trial (Colchicine 0.5 MG, Placebo)
Not yet recruiting
- Inflammatory Response
- Cardiac Disease
- Colchicine 0.5 MG
- Placebo
- (no location specified)
Nov 1, 2023
Through Detection of Elastase-1 Combined With Other Examinations
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +5 more
- Pancreatic elastase-1 in blood serum
-
Jinan, Shandong, ChinaNing Zhong
Sep 10, 2023
Myeloid-derived Suppressor Cells in Colorectal Cancer
Completed
- Colorectal Cancer
- +3 more
- Level of Myeloid-Derived Suppressor Cells
-
Krakow, Malopolska, Poland1st Department of General Surgery
Jul 3, 2022